Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of Endoscopic Ultrasound Radiofrequency Ablation (EUS RFA) in the Management of Not Resectable Pancreatic Cancer.

NCT04164992 is registered in ClinicalTrials.gov with Campus Bio-Medico University as lead sponsor.

NCT NCT04164992
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04164992 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of Endoscopic Ultrasound Radiofrequency Ablation (EUS RFA) in the Management of Not Resectable Pancreatic Cancer.
Lead sponsor
Campus Bio-Medico University
Phase
Not applicable
Overall status
Unknown status
Start date
November 15, 2019
Completion date
November 15, 2021
Enrollment
15 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic ductal adenocarcinoma